The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Wed., Aug. 4, 10:43 AM

Slide #17. LeMaitre Vascular, Inc. Secondary Offering

Company: LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Date announced: 7/13/2021
Shares Offered: 1,000,000
Date of Pricing: 7/13/2021
Price Per Share: $54.50
Secondary Offering Details: LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering will be offered by LeMaitre. In addition, LeMaitre intends to grant to the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering, on the same terms and conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. -updated 7/13- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritten public offering of 1,000,000 shares of its common stock at a public offering price of $54.50 per share. Gross proceeds to LeMaitre from the offering are expected to be approximately $54.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by LeMaitre. The offering is expected to close on or about July 16, 2021, subject to customary closing conditions. LeMaitre has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 150,000 shares of common stock at the public offering price, less underwriting discounts and commissions.

LeMaitre Vascular is a provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease, end-stage renal disease, and to a lesser extent cardiovascular disease. Co. develops, manufactures, and markets vascular devices to address the needs of vascular surgeons. Co.'s portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and includes the LeMaitre valvulotome, the XenoSure biologic patch, the Artegraft collagen vascular graft, the Pruitt F3 carotid shunt, VascuTape radiopaque tape, and Syntel embolectomy catheters.

LMAT SEC Filing Email Alerts Service

Open the LMAT Page at The Online Investor »

Company Name:  LeMaitre Vascular Inc
Sector:  Medical Instruments & Supplies
Number of ETFs Holding LMAT:  45
Total Market Value Held by ETFs:  $196.62M
Total Market Capitalization:  $1.13B
% of Market Cap. Held by ETFs:  17.45%

Open the LMAT Page at The Online Investor (in a new window) »

August 4, 2021    10:43 AM Eastern
Quotes delayed 20 minutes

Hold (2.50 out of 4)
1st percentile
(ranked lower than approx. 99% of all stocks covered)

Analysts' Target Price:
LMAT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2021, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.